A study by the U.S. Department of Veterans Affairs found that home anticoagulation monitoring of patients on warfarin (Coumadin) was as effective as testing at the hospital clinic.

Thus, for those that can’t easily get to the hospital clinic, home INR (International Normalized Ratio) monitoring can be an effective and safe alternative. And Medicare now covers home testing, as do many insurance companies.

Read more: Home Anticoagulation Monitoring Is An Effective Alternative to Coumadin Clinics

Tags: Anticoagulation, Treatment //

Related Posts

• FDA Approves the AtriClip for Atrial Fibrillation Stroke Prevention, and Other Devices Are Being Tested
• Are you at risk of bleeding from anticoagulants Coumadin or warfarin: New “HAS-BLED” tool assesses risk for those with atrial fibrillation
• FDA Update on the WATCHMAN® Left Atrial Appendage (LAA) Closure Device to Prevent Strokes in Atrial Fibrillation Patients
• Gene Test Improves Coumadin (warfarin) Use for Stroke Prevention in Atrial Fibrillation (AF)
• New Atrial Fibrillation (AF) Stroke Risk Factors Reveal That More Should Be on Coumadin or Warfarin, Especially Women
• Video to Help Safely Manage Blood Thinners Coumadin and Warfarin
• Higher Risk of Stroke and Death for Women with Atrial Fibrillation
• Blood Clots and Near-Stroke Motivated Survivor to Launch Atrial Fibrillation Month in September to Focus on Arrhythmia That Causes Stroke
• Dabigatran Beats Warfarin for Stroke Prevention in Atrial Fibrillation
• FDA to Review Atritech Watchman Device As Alternative to Warfarin or Coumadin in Preventing Strokes From Atrial Fibrillation
• Device Offers Alternative to Warfarin or Coumadin in Preventing Strokes From Atrial Fibrillation
• Video: Dabigatran and Rivaroxaban are possible Coumadin replacements
• Video: Do you Need Coumadin or Warfarin?
• Focus on Preventing Silent Strokes for World Stroke Day
• AV Node Ablation: Why You Shouldn’t Have It